The additive value of patch testing with patients' own products at an occupational dermatology clinic

Dan Slodownik, Jason Williams, Kathryn Frowen, Amanda Palmer, Melanie C. Matheson, Rosemary Nixon

Contact Dermatitis · 2009 · 24 citations · 13 references

Concepts

Abstract

BACKGROUND AND OBJECTIVES: Patch testing with commercially available kits detects only 70-80% of relevant allergens in patients with contact dermatitis. This is not ideal, especially when occupational issues are being evaluated. This study analyses our data regarding reactions to patients' own products. METHODS: In a 5-year period, 1532 patients were assessed in our occupational dermatology clinic. RESULTS: We found that 101 patients (6.6%) reacted to their own samples. In 20 (1.3%) cases, reacting to their own samples was the only clue for detecting the responsible allergen. In 59 (3.9%) cases, testing with their own samples reinforced their reactions to commercial allergens. CONCLUSIONS: We found the overall additive value of testing with patients' own products to be 5.2%. This is not a low proportion considering the 20-30% false negative rate when patch testing. Patch testing with patients' own samples, appropriately diluted should be undertaken whenever possible.

References

13